SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001610618-22-000068
Filing Date
2022-08-09
Accepted
2022-08-09 17:07:05
Documents
62
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 CIDARA THERAPEUTICS, INC. FORM 10-Q cdtx-20220630.htm   iXBRL 10-Q 1564707
2 FIFTH AMENDMENT TO LOAN AND SECURITY AGREEMENT exhibit1012022-06.htm EX-10.1 15634
3 MUNDIPHARMA LETTER AGREEMENT exhibit1022022-06.htm EX-10.2 31765
4 CERTIFICATION OF CEO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934 exhibit3112022-06.htm EX-31.1 9948
5 CERTIFICATION OF CFO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934 exhibit3122022-06.htm EX-31.2 9924
6 CERTIFICATION OF CEO PURSUANT TO SARBANES-OXLEY ACT OF 2002 exhibit3212022-06.htm EX-32.1 7451
7 CERTIFICATION OF CFO PURSUANT TO SARBANES-OXLEY ACT OF 2002 exhibit3222022-06.htm EX-32.2 7486
  Complete submission text file 0001610618-22-000068.txt   6594109

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cdtx-20220630.xsd EX-101.SCH 38184
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cdtx-20220630_cal.xml EX-101.CAL 49919
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cdtx-20220630_def.xml EX-101.DEF 236610
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cdtx-20220630_lab.xml EX-101.LAB 524164
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cdtx-20220630_pre.xml EX-101.PRE 350199
56 EXTRACTED XBRL INSTANCE DOCUMENT cdtx-20220630_htm.xml XML 1048671
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36912 | Film No.: 221149316
SIC: 2836 Biological Products, (No Diagnostic Substances)